Vickie Brown-Driver
9Patents
5h-index
25Co-inventors
59Inventor score
Filing activity: Mar 12, 1993 → May 6, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5514577A | Oligonucleotide therapies for modulating the effects of herpes viruses | Chemistry; Metallurgy | 91 | Expired |
| US7067497B2 | Modulation of telomere length by oligonucleotides having a G-core sequence | Chemistry; Metallurgy | 47 | Expired |
| US8101743B2 | Modulation of transthyretin expression | Emerging Cross-Sectional Technologies | 40 | Active |
| US5952490A | Oligonucleotides having a conserved G4 core sequence | Chemistry; Metallurgy | 38 | Expired |
| US5698391A | Methods for synthetic unrandomization of oligomer fragments | Physics | 20 | Expired |
| US6187587A | Antisense inhibition of e2f transcription factor 1 expression | Emerging Cross-Sectional Technologies | 5 | Expired |
| US8021665B2 | Identification and application of antibiotic synergy | Emerging Cross-Sectional Technologies | 1 | Active |
| US8298543B2 | Identification and application of antibiotic synergy | Emerging Cross-Sectional Technologies | 0 | Active |
| US7910337B2 | Method for identifying drug-sensitizing antisense DNA fragments and use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.